| scholarly article | Q13442814 |
| P50 | author | Carlos Eduardo Leite Arieta | Q56866884 |
| P2093 | author name string | Heitor Panetta | |
| Andre Luis A Fonseca | |||
| Mauricio A Nascimento | |||
| Rodrigo Pessoa C Lira | |||
| P2860 | cites work | A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema | Q33355710 |
| Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: a systematic review | Q33438145 | ||
| Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema | Q33567438 | ||
| Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study | Q33696777 | ||
| Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study | Q33730079 | ||
| Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema | Q33860902 | ||
| The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. | Q33860909 | ||
| Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. | Q34157994 | ||
| Imaging retinal inflammatory biomarkers after intravitreal steroid and anti-VEGF treatment in diabetic macular oedema. | Q51366968 | ||
| Progression of diabetic retinopathy severity after treatment with dexamethasone implant: a 24-month cohort study the 'DR-Pro-DEX Study'. | Q52677859 | ||
| Changes in aqueous concentrations of various cytokines after intravitreal triamcinolone versus bevacizumab for diabetic macular edema | Q84586581 | ||
| Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant | Q84724214 | ||
| Diabetic macular edema | Q84724864 | ||
| Long-term efficacy and safety profile of multiple injections of intravitreal dexamethasone implant to manage diabetic macular edema: A systematic review of real-world studies | Q90024592 | ||
| Epidemiology of diabetic retinopathy and macular oedema: a systematic review | Q34330907 | ||
| Treatment of diabetic macular edema with sustained-release glucocorticoids: intravitreal triamcinolone acetonide, dexamethasone implant, and fluocinolone acetonide implant. | Q35128723 | ||
| Intravitreal aflibercept for diabetic macular edema | Q35205053 | ||
| Dexamethasone Implants in Patients with Naïve or Refractory Diffuse Diabetic Macular Edema | Q35557658 | ||
| Diabetic Macular Edema: Pathophysiology and Novel Therapeutic Targets | Q35620981 | ||
| Trabecular meshwork and lens partitioning of corticosteroids: implications for elevated intraocular pressure and cataracts | Q36124980 | ||
| Early response to ranibizumab predictive of functional outcome after dexamethasone for unresponsive diabetic macular oedema | Q36353933 | ||
| Preliminary results of an intravitreal dexamethasone implant (Ozurdex®) in patients with persistent diabetic macular edema | Q37038541 | ||
| Glucocorticoids: structure, signaling and molecular mechanisms in the treatment of diabetic retinopathy and diabetic macular edema | Q38182127 | ||
| Long-term Effects of Intravitreal 0.19 mg Fluocinolone Acetonide Implant on Progression and Regression of Diabetic Retinopathy | Q39024005 | ||
| Evaluation of the Retinal Toxicity and Pharmacokinetics of Dexamethasone After Intravitreal Injection | Q41915913 | ||
| Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. | Q45133527 | ||
| Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients With Persistent Diabetic Macular Edema: A DRCR Network Phase 2 Randomized Clinical Trial | Q45305404 | ||
| Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients | Q46064973 | ||
| Mechanisms of macular edema: Beyond the surface. | Q47415381 | ||
| Treatment of anti-vascular endothelial growth factor-resistant diabetic macular edema with dexamethasone intravitreal implant | Q47706263 | ||
| Pharmacology of Corticosteroids for Diabetic Macular Edema | Q47753853 | ||
| Novel therapeutic targets in diabetic macular edema: Beyond VEGF. | Q49380314 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | dexamethasone | Q422252 |
| P304 | page(s) | 1523-1531 | |
| P577 | publication date | 2019-08-09 | |
| P1433 | published in | Clinical Ophthalmology | Q5133782 |
| P1476 | title | Effect of intravitreal dexamethasone solution on the reduction of macular thickness in pseudophakic diabetic patients in a public hospital in Brazil: a randomized clinical trial | |
| P478 | volume | 13 |
Search more.